Microglia, the first line of defence in brain pathologies - PubMed (original) (raw)
Review
. 1995 Mar;45(3A):357-60.
Affiliations
- PMID: 7763326
Review
Microglia, the first line of defence in brain pathologies
G W Kreutzberg. Arzneimittelforschung. 1995 Mar.
Abstract
Microglial cells account for approximately 20% of the total glial population in the central nervous system. They are distributed with no significant local differences in the white and grey matters. In contrast to astrocytes they cover non-overlapping territories. They belong to the mononuclear phagocyte system and form the resident macrophages in the brain tissue, the spinal cord and the retina. Their function in the normal neural parenchyma is unknown. However, in various pathologies they form a most reactive sensor to threats to the nervous system. Within a few hours they exhibit an activation program that we have studied in seven different experimental paradigms, e.g. following nerve section, direct brain trauma, toxic lesion, spreading depression, ischemic lesion, fiber degeneration, autoimmune diseases. Activated microglial cells become immuno-competent and are MHC (major histocompatibility complex) class 1 and class 2 positive. They express the amyloid precursor protein, APP. The complement receptor CR3bi is quickly upregulated. The mitotic activity depends on the colony stimulating factors M-CSF and GM-CSF and the appropriate receptors. Molecules discussed as signals in the activation process of microglia are cytokines such as IL-1, IL-2, IL-6, TGF beta 1. An important role could also be attributed to the unique potassium channel of microglia. Brain macrophages of microglial origin have a strong respiratory burst activity, meaning that they produce oxygen radicals. They also possess Cathepsin B and L and thus are potentially cytotoxic. Taken together, microglia are highly reactive, mobile and multifunctional immune cells of the CNS that can play a universal role in the defence of the neural parenchyma.
Similar articles
- Microglia and the early phase of immune surveillance in the axotomized facial motor nucleus: impaired microglial activation and lymphocyte recruitment but no effect on neuronal survival or axonal regeneration in macrophage-colony stimulating factor-deficient mice.
Kalla R, Liu Z, Xu S, Koppius A, Imai Y, Kloss CU, Kohsaka S, Gschwendtner A, Möller JC, Werner A, Raivich G. Kalla R, et al. J Comp Neurol. 2001 Jul 23;436(2):182-201. J Comp Neurol. 2001. PMID: 11438923 - Generation and characterization of immortalized human microglial cell lines: expression of cytokines and chemokines.
Nagai A, Nakagawa E, Hatori K, Choi HB, McLarnon JG, Lee MA, Kim SU. Nagai A, et al. Neurobiol Dis. 2001 Dec;8(6):1057-68. doi: 10.1006/nbdi.2001.0437. Neurobiol Dis. 2001. PMID: 11741401 - The microglial networks of the brain and their role in neuronal network plasticity after lesion.
Cullheim S, Thams S. Cullheim S, et al. Brain Res Rev. 2007 Aug;55(1):89-96. doi: 10.1016/j.brainresrev.2007.03.012. Epub 2007 Apr 19. Brain Res Rev. 2007. PMID: 17509690 Review. - Microglia in normal condition and pathology.
Pivneva TA. Pivneva TA. Fiziol Zh (1994). 2008;54(5):81-9. Fiziol Zh (1994). 2008. PMID: 19058517 Review.
Cited by
- Cathepsin B as a cancer target.
Gondi CS, Rao JS. Gondi CS, et al. Expert Opin Ther Targets. 2013 Mar;17(3):281-91. doi: 10.1517/14728222.2013.740461. Epub 2013 Jan 8. Expert Opin Ther Targets. 2013. PMID: 23293836 Free PMC article. Review. - Nicotinic modulation of innate immune pathways via α7 nicotinic acetylcholine receptor.
Cui WY, Li MD. Cui WY, et al. J Neuroimmune Pharmacol. 2010 Dec;5(4):479-88. doi: 10.1007/s11481-010-9210-2. Epub 2010 Apr 13. J Neuroimmune Pharmacol. 2010. PMID: 20387124 Review. - Events Occurring in the Axotomized Facial Nucleus.
Nakajima K, Ishijima T. Nakajima K, et al. Cells. 2022 Jun 29;11(13):2068. doi: 10.3390/cells11132068. Cells. 2022. PMID: 35805151 Free PMC article. Review. - A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis.
Plantone D, Inglese M, Salvetti M, Koudriavtseva T. Plantone D, et al. Front Neurol. 2019 Jan 14;9:1175. doi: 10.3389/fneur.2018.01175. eCollection 2018. Front Neurol. 2019. PMID: 30692962 Free PMC article. Review. - Impact of non-neuronal cells in Alzheimer's disease from a single-nucleus profiling perspective.
Vu TM, Hervé V, Ulfat AK, Lamontagne-Kam D, Brouillette J. Vu TM, et al. Front Cell Neurosci. 2023 Jun 14;17:1208122. doi: 10.3389/fncel.2023.1208122. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37388411 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Research Materials